Use of adenosine in patients hospitalized in a University Medical Center

American Journal of Medicine

Volumn 105, Issue 4, 1998, Pages 275-280

  Knight, Bradley P ^a,b   Zivin, Adam ^a   Souza, Joseph ^a   Goyal, Rajiva ^a   Man, K Ching ^a   Strickberger, S Adam ^a   Morady, Fred ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE;

ADULT; AGED; ARTICLE; ASYSTOLE; CLINICAL EDUCATION; DIAGNOSTIC ERROR; DOSE RESPONSE; DRUG MISUSE; DRUG UTILIZATION; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HOSPITAL CARE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QRS COMPLEX; SUPRAVENTRICULAR TACHYCARDIA; UNIVERSITY HOSPITAL;

ADENOSINE; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; TACHYCARDIA;

EID: 0032191067     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00261-7     Document Type: Article

References (25)

1. 1. DiMarco JP, Sellers D, Lerman BB, et al. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol. 1985;6:417-425.
2. 2. DiMarco JP, Miles W, Akhtar M, et al, for the Adenosine for PSVT Study Group. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Ann Intern Med. 1990;113:104-110.
3. 3. Hood MA, Smith WM. Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover trial. Am Heart J. 1992;123:1543-1549.
4. 4. Cairns CB, Niemann JT. Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia. Ann Emerg Med. 1991;20:717-721.
5. 5. Marco CA, Cardinale JF. Adenosine for the treatment of supraventricular tachycardia in the ED. Am J Emerg Med. 1994;12: 485-488.
6. 6. Rossi AF, Steinberg GL, Kipel G, et al. Use of adenosine in the management of perioperative arrhythmias in the pediatric cardiac intensive care unit. Crit Care Med. 1992;20:1107-1111.
7. 7. Brady WJ, DeBehnke DJ, Wickman LL, Lindbeck G. Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil. Acad Emerg Med. 1996;3:574-585.
8. 8. Camm AJ, Garratt CJ. Adenosine and supraventricular tachycardia. NEJM. 1991;325:1621-1629.
9. 9. Rankin AC, Brooks R, Ruskin J, McGovern BA. Adenosine and the treatment of supraventricular tachycardia. Am J Cardiol. 1992;92: 655-664.
10. 10. Bigger JT. Cardiac arrhythmias. In: Wyngaarden JB, Smith LH, Bennett JC, eds. Cecil Textbook of Medicine. 20th ed. Philadelphia: WB Sanders; 1996:240-241.
11. 11. Zipes DP. Cardiac arrhythmias. In: Kelley WN, ed. Textbook of Internal Medicine. 3rd ed. Philadelphia: JB Lippincott; 1997: 416-417.
12. 12. Josephson ME, Zimetbaum P, Buxton AE, Marchlinski FE. The tachyarrhythmias. In: Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine. 14th ed. New York: McGraw-Hill; 1998:1264-1265.
13. 13. Kastor JA. Multifocal atrial tachycardia. NEJM. 1990;322;24:1713-1717.
14. 14. Zipes DP. Specific arrhythmias: diagnosis and treatment. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 4th ed. Philadelphia: WB Saunders; 1992.
15. 15. Cushley MJ, Tattersfield AE, Holgate ST. Adenosine-induced bronchospasm in asthma. Antagonism by inhaled theophylline. Am Rev Respir Dis. 1984;129:380-384.
16. 16. Nunain SO, Garratt C, Paul V, et al. Effect of intravenous adenosine on human atrial and ventricular repolarisation. Cardiovasc Res. 1992;26:939-943.
17. 17. Tebbenjohanns J, Pfeiffer D, Schumacher B, et al. Intravenous adenosine during atrioventricular reentrant tachycardia: Induction of atrial fibrillation with rapid conduction over an accessory pathway. PACE. 1995;18:743-746.
18. 18. Exner DV, Muzyka T, Gillis AM. Proarrhythmia in patients with the Wolff-Parkinson-White syndrome after standard doses of intravenous adenosine. Ann Intern Med. 1995;122:351-352.
19. 19. Garratt CJ, O'Nunain S, Griffith M, et al. Effects of intravenous adenosine in patients with preexcited junctional tachycardias: therapeutic efficacy and incidence of proarrhythmic events. Am J Cardiol. 1994;74:401-404.
20. 20. Strickberger SA, Man KC, Daoud EG, et al. Adenosine-induced atrial arrhythmia: a prospective analysis. Ann Intern Med. 1997;127: 417-422.
21. 21. Orebaugh SL, Handy M. Intravenous adenosine therapy accelerating rate of paroxysmal supraventricular tachycardia. Am J Emerg Med. 1992;10:326-330.
22. 22. Slade AKB, Garret CJ. Proarrhythmic effect of adenosine in a patient with atrial flutter. Br Heart J. 1993;70:91-92.
23. 23. Rankin AC, Rae AP, Houston A. Acceleration of ventricular response to atrial flutter after intravenous adenosine. Br Heart J. 1993; 69:263-265.
24. 24. Brodsky MA, Hwang C, Hunter D, et al. Life-threatening alterations in heart rate after the use of adenosine in atrial flutter. Am Heart J. 1995;130:546-571.
25. 25. Smith JR, Goldberger JJ, Kadish AH. Adenosine induced polymorphic ventricular tachycardia in adults without structural heart disease. PACE. 1997;20:743-745.